nach oben

Translational Stroke Research

Erschienen in:

24.02.2017 | Commentary

Can Quality Improvement Tools Overcome the Translational Roadblock—the Vital Influence of the Researcher

verfasst von: Serge Marbacher

Erschienen in: Translational Stroke Research | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Excerpt

Both special issues “Challenges and Controversies in Translational Stroke Research, Part 1 and 2” provide an excellent overview of the methodological challenges encountered in the various stages of planning, implementation, and evaluation of preclinical stroke studies. The topics discussed do not apply solely to the field of stroke research, but to many other fields of translational science as well. This collection of articles by highly informed scientists clearly illustrates that a multitude of approaches and measures is needed to address bias in preclinical research in order to increase the translation of knowledge from basic science to clinical practice. …

Boltze J, Wagner DC, Henninger N, Plesnila N, Ayata C. Phase iii preclinical trials in translational stroke research: community response on framework and guidelines. Transl Stroke Res. 2016;7:241–7.CrossRefPubMedPubMedCentral

Ahnstedt H, McCullough LD, Cipolla MJ. The importance of considering sex differences in translational stroke research. Transl Stroke Res. 2016;7:261–73.CrossRefPubMed

Becker KJ. Strain-related differences in the immune response: relevance to human stroke. Transl Stroke Res. 2016;7:303–12.CrossRefPubMed

Kent TA, Mandava P. Embracing biological and methodological variance in a new approach to pre-clinical stroke testing. Transl Stroke Res. 2016;7:274–83.CrossRefPubMed

Ergul A, Hafez S, Fouda A, Fagan SC. Impact of comorbidities on acute injury and recovery in preclinical stroke research: focus on hypertension and diabetes. Transl Stroke Res. 2016;7:248–60.CrossRefPubMed

Hoffmann U, Sheng H, Ayata C, Warner DS. Anesthesia in experimental stroke research. Transl Stroke Res. 2016;7:358–67.CrossRefPubMed

Hommel M, Detante O, Favre I, Touze E, Jaillard A. How to measure recovery? Revisiting concepts and methods for stroke studies. Transl Stroke Res. 2016;7:388–94.CrossRefPubMed

Muir KW, Macrae IM. Neuroimaging as a selection tool and endpoint in clinical and pre-clinical trials. Transl Stroke Res. 2016;7:368–77.CrossRefPubMedPubMedCentral

Jolkkonen J, Kwakkel G. Translational hurdles in stroke recovery studies. Transl Stroke Res. 2016;7:331–42.CrossRefPubMed

10.

Richter SH, Garner JP, Wurbel H. Environmental standardization: cure or cause of poor reproducibility in animal experiments? Nat Methods. 2009;6:257–61.CrossRefPubMed

11.

Baker D, Lidster K, Sottomayor A, Amor S. Two years later: journals are not yet enforcing the arrive guidelines on reporting standards for pre-clinical animal studies. PLoS Biol. 2014;12:e1001756.CrossRefPubMedPubMedCentral

12.

Reichlin TS, Vogt L, Wurbel H. The researchers’ view of scientific rigor-survey on the conduct and reporting of in vivo research. PLoS One. 2016;11:e0165999.CrossRefPubMedPubMedCentral

13.

Stroke Therapy Academic Industry R. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999;30:2752–8.CrossRef

14.

Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M, Consortium SV. Stroke therapy academic industry roundtable (stair) recommendations for extended window acute stroke therapy trials. Stroke. 2009;40:2594–600.CrossRefPubMedPubMedCentral

15.

Stem Cell Therapies as an Emerging Paradigm in Stroke P. Stem cell therapies as an emerging paradigm in stroke (steps): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke. 2009;40:510–5.CrossRef

16.

Savitz SI, Chopp M, Deans R, Carmichael T, Phinney D, Wechsler L, et al. Stem cell therapy as an emerging paradigm for stroke (steps) ii. Stroke. 2011;42:825–9.CrossRefPubMed

17.

Lapchak PA, Zhang JH, Noble-Haeusslein LJ. Rigor guidelines: escalating stair and steps for effective translational research. Transl Stroke Res. 2013;4:279–85.CrossRefPubMed

18.

Cressey D. Web tool aims to reduce flaws in animal studies. Nature. 2016;531:128.CrossRefPubMed

19.

Smith MM, Clarke EC, Little CB. Considerations for the design and execution of protocols for animal research and treatment to improve reproducibility and standardization: “Depart well-prepared and arrive safely”. Osteoarthritis Cartilage. 2016.

20.

Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the arrive guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412.CrossRefPubMedPubMedCentral

21.

Hooijmans CR, Leenaars M, Ritskes-Hoitinga M. A gold standard publication checklist to improve the quality of animal studies, to fully integrate the three rs, and to make systematic reviews more feasible. Altern Lab Anim. 2010;38:167–82.PubMed

22.

Dirnagl U, Fisher M. International, multicenter randomized preclinical trials in translational stroke research: it’s time to act. J Cereb Blood Flow Metab. 2012;32:933–5.CrossRefPubMedPubMedCentral

23.

Bath PM, Macleod MR, Green AR. Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke. Int J Stroke. 2009;4:471–9.CrossRefPubMed

Titel: Can Quality Improvement Tools Overcome the Translational Roadblock—the Vital Influence of the Researcher
verfasst von: Serge Marbacher
Publikationsdatum: 24.02.2017
Verlag: Springer US
Erschienen in: Translational Stroke Research / Ausgabe 3/2017
Print ISSN: 1868-4483
Elektronische ISSN: 1868-601X
DOI: https://doi.org/10.1007/s12975-017-0524-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

A Systematic and Meta-Analysis of Mortality in Experimental Mouse Models Analyzing Delayed Cerebral Ischemia After Subarachnoid Hemorrhage

Inhibition of Blood-Brain Barrier Disruption by an Apolipoprotein E-Mimetic Peptide Ameliorates Early Brain Injury in Experimental Subarachnoid Hemorrhage

Evolutional Characterization of Photochemically Induced Stroke in Rats: a Multimodality Imaging and Molecular Biological Study

DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury

Sex Differences in the Cerebral Collateral Circulation

Antiplatelet Strategies and Outcomes in Patients with Noncardioembolic Ischemic Stroke from a Real-World Study with a Five-Year Follow-Up